| A comprehensive review on the antiviral activities of chalcones D Elkhalifa, I Al-Hashimi, AE Al Moustafa, A Khalil Journal of Drug Targeting 29 (4), 403-419, 2021 | 111 | 2021 |
| Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer D Elkhalifa, AB Siddique, M Qusa, FS Cyprian, K El Sayed, F Alali, ... European Journal of Medicinal Chemistry 187, 111954, 2020 | 48 | 2020 |
| Chemically modified mRNA beyond COVID-19: potential preventive and therapeutic applications for targeting chronic diseases D Elkhalifa, M Rayan, AT Negmeldin, A Elhissi, A Khalil Biomedicine & Pharmacotherapy 145, 112385, 2022 | 23 | 2022 |
| Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight D Elkhalifa, F Alali, AE Al Moustafa, A Khalil Journal of drug targeting, 1-9, 2018 | 19 | 2018 |
| Novel nitrogen-based chalcone analogs provoke substantial apoptosis in HER2-positive human breast cancer cells via JNK and ERK1/ERK2 signaling pathways B Rizeq, I Gupta, H Kheraldine, D Elkhalifa, HF Al-Farsi, AEA Moustafa, ... International Journal of Molecular Sciences 22 (17), 9621, 2021 | 10 | 2021 |
| Novel polymethoxylated chalcones as potential compounds against KRAS-mutant colorectal cancers A Mahmoud, D Elkhalifa, F Alali, AE Al Moustafa, A Khalil Current Pharmaceutical Design 26 (14), 1622-1633, 2020 | 10 | 2020 |
| Characteristics and quality of adverse drug reaction reporting: a comparison of pharmacists with other healthcare providers at a multi-specialty hospital in Qatar N Alsalimy, D Elkhalifa, AA Shammaa, M Magdy, A Awaisu Drugs & Therapy Perspectives 33, 283-289, 2017 | 5 | 2017 |
| Utilization of evidence-based secondary prevention medications at the time of discharge in patients with acute coronary syndrome (ACS) in Qatar M S. El-Hajj, A Saad, J Al-Suwaidi, W Z. Al-Marridi, D H. Elkhalifa, ... Current Vascular Pharmacology 14 (4), 394-403, 2016 | 4 | 2016 |
| Curriculum, competency development, and assessment methods of MSc and PhD pharmacy programs: a scoping review D ElKhalifa, O Hussein, A Hamid, N Al-Ziftawi, I Al-Hashimi, MIM Ibrahim BMC Medical Education 24 (1), 989, 2024 | 2 | 2024 |
| Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials D ElKhalifa, N Al-Ziftawi, A Awaisu, F Alali, A Khalil Frontiers in Oncology 13, 1251895, 2023 | 2 | 2023 |
| Characteristics and quality of adverse drug reaction reporting among healthcare providers at Rumailah Hospital in Qatar N Alsalimy, M Magdy, D Elkhalifa, A Al Shammaa, A Awaisu Qatar Medical Journal 2017 (3), 2, 2016 | 1 | 2016 |
| Exploring Transarterial Radioembolization and Chemoembolization in Hepatocellular Carcinoma: A Comprehensive Literature and Case-Based Analysis S Zoghoul, I Al-Hashimi, D Elkhalifa, A Alani, A Barah The Arab Journal of Interventional Radiology 8 (S 01), A275, 2024 | | 2024 |
| Novel chalcone-based chemotherapeutic compound for triple negative breast cancer A Khalil, AE Al Moustafa, DH Elkhalifa, F Alali US Patent App. 18/226,638, 2023 | | 2023 |
| Novel chalcone-based chemotherapeutic compound for triple negative breast cancer A Khalil, AE Al Moustafa, DH Elkhalifa, F Alali US Patent US-2020-0392119-A1, 2020 | | 2020 |
| Design and Development of Three-Dimensional Biodegradable Electrospun Nanofibrous Scaffolds for Wound Healing and other Tissue Engineering Applications Dana Elkhalifa, Aya Al Shammaa, Mai Salama, Hala Adel, Sarah Ghanim, Samaher ... Paper presented at 28th Annual Conference of The European Society for …, 2017 | | 2017 |